Lyell Immunopharma (LYEL) Payables (2020 - 2026)
Lyell Immunopharma (LYEL) reported Payables of $3.88 million for Q2 2026, up 14.8% from $3.38 million a year earlier but down 29.1% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Lyell Immunopharma posted Payables of $2.89 million, down 46.1% from FY2024.
- Payables has a five-year compound annual growth rate of -21.0% (FY2020 to FY2025).
- By year, Payables came in at $5.37 million in FY2024 (+11.4%), $4.82 million in FY2023 (+23.0%), $3.92 million in FY2022 (+22.1%) and $3.21 million in FY2021 (-65.9%).
- Five-year quarterly Payables spans a low of $2.57 million in Q3 2025 and a high of $6.51 million in Q1 2022.
- Year over year, Payables gained in three of the last eight quarters, with an average decline of 7.8%.
- The high point for year-over-year Payables in five years was Q1 2026 (growth of 46.7%); the low point was Q4 2021 (a decline of 65.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.47 million (Q1 2026), $2.89 million (Q4 2025) and $2.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Lyell Immunopharma | 411.74 Mn | -470.71 Mn | - | 4.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.04 Mn |
| Jun 30, 2026 | 3.88 Mn |
| Mar 31, 2026 | 5.47 Mn |
| Dec 31, 2025 | 2.89 Mn |
| Sep 30, 2025 | 2.57 Mn |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 5.37 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | 4.20 Mn |
| Mar 31, 2024 | 4.90 Mn |
| Dec 31, 2023 | 4.82 Mn |
| Sep 30, 2023 | 4.37 Mn |
| Jun 30, 2023 | 5.81 Mn |
| Mar 31, 2023 | 5.73 Mn |
| Dec 31, 2022 | 3.92 Mn |
| Sep 30, 2022 | 4.80 Mn |
| Jun 30, 2022 | 4.25 Mn |
| Mar 31, 2022 | 6.51 Mn |
| Dec 31, 2021 | 3.21 Mn |
API Access
Lyell Immunopharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();